NUXP Insider Trading Activity and SEC Form 4 Filings
NUXP insider trading summary
No open-market insider purchases or sales of Nurx Pharmaceuticals, Inc. (NUXP) have been reported on SEC Form 4 in the past 12 months.
Latest NUXP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 13, 2009 | Harin Padma-Nathan | Director | Buy | $50K (200,000 @ $0.25) |
| Oct 13, 2009 | Sharyar Baradaran | Director | Buy | $50K (200,000 @ $0.25) |
| Sep 29, 2009 | Hunter World Markets, Inc. | 10% Owner | Sell | $200K (999,999 @ $0.20) |
| Sep 23, 2009 | Sharyar Baradaran | Director | Buy | $0 (900,000 @ $0.00) |
| Sep 23, 2009 | Harin Padma-Nathan | Director | Buy | $0 (99,999 @ $0.00) |
| May 18, 2009 | Hunter World Markets, Inc. | 10% Owner | Sell | $240K (1,090,558 @ $0.22) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.